 |
|
|
Resources for Patients & Families |
|
Researcher Highlight: Dr. Robert Bowser |
|
For the past 20 years, Robert Bowser, PhD, has been studying how the regulation of gene expression is involved in neurodegenerative diseases. Learn more about Dr. Bowser's work>> |
|
Clinical Research Update April 2012 |
What is coming down the ALS research pipeline? Learn more about enrolling trials, trial announcements, and upcoming webinars.
Read more>>
Clinical Trials 101: Definitions
NEALS has compiled a glossary of terms used throughout this website. Learn more about what it means to be in a clinical trial.
See the list>>
|
|
|
|
|
|
|
Resources for Researchers |
|
TREAT ALS Request for Proposals |
|
Applications are being accepted for a clinical research pilot study and for clinical management studies. Deadline for brief study outline is May 28,2012. Learn More>> |
|
The 11th Annual NEALS Meeting |
The 11th Annual NEALS Meeting will take place in Clearwater Beach, FL on Wednesday, October 24th through Friday, October 26th, 2012.
Read More>>
NEALS Samples
Learn more about the tissue and fluid samples NEALS has available for research efforts in ALS and motor neuron diseases. Read More>>
|
|
|
|
|
|
|
News & Events |
|
|
|
|
A Powerful New Clinical Research Resource: PRO-ACT Database |
The Pooled Resource Open-Access ALS Clinical Trial Platform will be accessible to ALS researchers to mine. Read more.
|
Cytokinetics Drug Receives Fast Track Designation
Cytokinetics Announces CK-2017357 Receives Fast Track Designation from the FDA for the Potential Treatment of ALS. Read the Press Release. |
Cogane™ Shown to be Effective in Pre-Clinical Models of ALS
Cogane™ reduced the loss of spinal cord motor neurons by 39% in a pre-clinical model with a mutation of the SOD1 gene.
Read the Press Release.
|
|
|
